Karine Breckpot
Karine Breckpot
Dirección de correo verificada de vub.ac.be
TítuloCitado porAño
Consensus guidelines for the detection of immunogenic cell death
O Kepp, L Senovilla, I Vitale, E Vacchelli, S Adjemian, P Agostinis, ...
Oncoimmunology 3 (9), e955691, 2014
3422014
Lentiviral vectors in gene therapy: their current status and future potential
D Escors, K Breckpot
Archivum immunologiae et therapiae experimentalis 58 (2), 107-119, 2010
2642010
Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules
A Bonehill, C Heirman, S Tuyaerts, A Michiels, K Breckpot, F Brasseur, ...
The Journal of Immunology 172 (11), 6649-6657, 2004
1982004
Current approaches in dendritic cell generation and future implications for cancer immunotherapy
S Tuyaerts, JL Aerts, J Corthals, B Neyns, C Heirman, K Breckpot, ...
Cancer Immunology, Immunotherapy 56 (10), 1513-1537, 2007
1972007
Lentivirally transduced dendritic cells as a tool for cancer immunotherapy
K Breckpot, M Dullaers, A Bonehill, S Van Meirvenne, C Heirman, ...
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2003
1812003
CD83 expression on dendritic cells and T cells: correlation with effective immune responses
C Aerts‐Toegaert, C Heirman, S Tuyaerts, J Corthals, JL Aerts, A Bonehill, ...
European journal of immunology 37 (3), 686-695, 2007
1792007
Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages
K Movahedi, S Schoonooghe, D Laoui, I Houbracken, W Waelput, ...
Cancer research 72 (16), 4165-4177, 2012
1702012
Combinatorial strategies for the induction of immunogenic cell death
L Bezu, LC Gomes-da-Silva, H Dewitte, K Breckpot, J Fucikova, R Spisek, ...
Frontiers in immunology 6, 187, 2015
1522015
Molecular and translational classifications of DAMPs in immunogenic cell death
AD Garg, L Galluzzi, L Apetoh, T Baert, RB Birge, BS Pedro, J Manuel, ...
Frontiers in immunology 6, 588, 2015
1442015
Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics
K Breckpot, JL Aerts, K Thielemans
Gene therapy 14 (11), 847, 2007
1422007
HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7
K Breckpot, D Escors, F Arce, L Lopes, K Karwacz, S Van Lint, M Keyaerts, ...
Journal of virology 84 (11), 5627-5636, 2010
1212010
Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy
S Van Lint, C Goyvaerts, S Maenhout, L Goethals, A Disy, D Benteyn, ...
Cancer research 72 (7), 1661-1671, 2012
1202012
Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors
M Dullaers, S Van Meirvenne, C Heirman, L Straetman, A Bonehill, ...
Gene therapy 13 (7), 630, 2006
1152006
Generation of large numbers of dendritic cells in a closed system using Cell Factories™
S Tuyaerts, SM Noppe, J Corthals, K Breckpot, C Heirman, C De Greef, ...
Journal of immunological methods 264 (1-2), 135-151, 2002
1152002
Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of d-luciferin: effect on intensity, time kinetics and …
M Keyaerts, J Verschueren, TJ Bos, LO Tchouate-Gainkam, C Peleman, ...
European journal of nuclear medicine and molecular imaging 35 (5), 999-1007, 2008
932008
Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines
A Michiels, S Tuyaerts, A Bonehill, J Corthals, K Breckpot, C Heirman, ...
Gene therapy 12 (9), 772, 2005
932005
Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+ CD25+ regulatory T cells
S Tuyaerts, S Van Meirvenne, A Bonehill, C Heirman, J Corthals, ...
Journal of leukocyte biology 82 (1), 93-105, 2007
872007
Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells
K Breckpot, C Heirman, B Neyns, K Thielemans
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2004
832004
Role of non-classical MHC class I molecules in cancer immunosuppression
G Kochan, D Escors, K Breckpot, D Guerrero-Setas
Oncoimmunology 2 (11), e26491, 2013
822013
Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function
S Zeissig, SK Dougan, DC Barral, Y Junker, Z Chen, A Kaser, M Ho, ...
The Journal of clinical investigation 120 (8), 2889-2899, 2010
802010
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20